Publication:
THE USE OF 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY TO ASSESS CLINICAL OUTCOMES OF PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC CANCER.

Simple item page
dc.contributor.authorDURMUS, A
dc.contributor.authorYILMAZ, A
dc.contributor.authorMalya, FATMA ÜMİT
dc.contributor.authorOZTURK, G
dc.contributor.authorBEKTASOGLU, HÜSEYİN KAZIM
dc.contributor.authorERTUGRUL, G
dc.contributor.authorKARYAGAR, S
dc.contributor.authorKARATEPE, O
dc.contributor.institutionauthorMALYA, FATMA ÜMİT
dc.contributor.institutionauthorBEKTAŞOĞLU, HÜSEYİN KAZIM
dc.date.accessioned2019-10-05T15:15:56Z
dc.date.available2019-10-05T15:15:56Z
dc.date.issued2016-04-01
dc.identifier
dc.identifier.citationDURMUS A., YILMAZ A., Malya F. Ü. , OZTURK G., BEKTASOGLU H. K. , ERTUGRUL G., KARYAGAR S., KARATEPE O., -THE USE OF 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY TO ASSESS CLINICAL OUTCOMES OF PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC CANCER.-, Georgian medical news, ss.26-9, 2016
dc.identifier.pubmed27249430
dc.identifier.scopus85015348643
dc.identifier.urihttps://hdl.handle.net/20.500.12645/5848
dc.language.isoen
dc.titleTHE USE OF 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY TO ASSESS CLINICAL OUTCOMES OF PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC CANCER.
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameT.C. Uludağ Üniversitesi Tıp Fakültesi Dergisi, 18, (1), 29-35, 1991
local.avesis.id9100cceb-a444-4bf5-aab8-fc348616ecad
local.avesis.response5718
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication0af18f13-53ee-4cbb-a171-30d8b1f8126e
relation.isAuthorOfPublication61e71b11-a2ad-495b-9e62-23b61f46432d
relation.isAuthorOfPublication.latestForDiscovery0af18f13-53ee-4cbb-a171-30d8b1f8126e
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files
Collections
Yayınlar - Eserler
Tıp Fakültesi